Skip to main content

In Vitro Biocompatibility and Macrophage Uptake Assays of Poly(Urea-Urethane) Nanoparticles Obtained by Miniemulsion Polymerization

Buy Article:

$107.14 + tax (Refund Policy)

In this work In Vitro cytotoxicity of poly(urea-urethane) nanoparticles obtained by miniemulsion polymerization against murine fibroblast (L929), normal human fibroblast (NIH3T3) and MRC-5 cell line derived from normal lung tissue, as well as, hemocompatibility, and In Vitro macrophage uptake were evaluated. From the results obtained in this work, poly(urea-urethane) nanoparticles showed spherical morphology, negative zeta potential and mean diameter of 85 ± 4 nm. In Vitro cytotoxicity against fibroblast cell lines L929, NIH-3T3, and MCR-5 showed no reduction of cell viability, which is a critical parameter for the drug carrier biocompatibility. In addition, in In Vitro macrophage uptake studies, poly(urea-urethane) nanoparticles showed a high phagocytic uptake, 72%. Hemolysis assays showed high human blood biocompatibility and the results indicate that poly(urea-urethane) nanoparticles obtained in this work have excellent properties without secondary effect, with potential application as carrier for drug delivery in the treatment of diseases in which macrophages act as host cells.

Keywords: Biomaterials; In Vitro Cytotoxicity; Miniemulsion Polymerization; Nanoparticles; Poly(Urea-Urethane)

Document Type: Research Article

Affiliations: 1: Department of Chemical Engineering and Food Engineering, Federal University of Santa Catarina, 88040970, Brazil 2: Department de Clinical Analysis, Federal University of Santa Catarina, 88040970, Brazil

Publication date: 01 July 2017

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content